table of content
1 Study Coverage
1.1 Influenza Drugs and Vaccines Product Introduction
1.2 Global Influenza Drugs and Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Influenza Drugs and Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Influenza Drugs and Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Influenza Drugs and Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Influenza Drugs and Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Influenza Drugs and Vaccines Sales in Volume for the Year 2017-2028
1.4 Influenza Drugs and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Influenza Drugs and Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Influenza Drugs and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Influenza Drugs and Vaccines Market Dynamics
1.5.1 Influenza Drugs and Vaccines Industry Trends
1.5.2 Influenza Drugs and Vaccines Market Drivers
1.5.3 Influenza Drugs and Vaccines Market Challenges
1.5.4 Influenza Drugs and Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Influenza Drugs and Vaccines Market Segment by Type
2.1.1 Influenza Drugs
2.1.2 Influenza Vaccines
2.2 Global Influenza Drugs and Vaccines Market Size by Type
2.2.1 Global Influenza Drugs and Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Influenza Drugs and Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Influenza Drugs and Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Influenza Drugs and Vaccines Market Size by Type
2.3.1 United States Influenza Drugs and Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Influenza Drugs and Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Influenza Drugs and Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Influenza Drugs and Vaccines Market Segment by Application
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Influenza Drugs and Vaccines Market Size by Application
3.2.1 Global Influenza Drugs and Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Influenza Drugs and Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Influenza Drugs and Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Influenza Drugs and Vaccines Market Size by Application
3.3.1 United States Influenza Drugs and Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Influenza Drugs and Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Influenza Drugs and Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Influenza Drugs and Vaccines Competitor Landscape by Company
4.1 Global Influenza Drugs and Vaccines Market Size by Company
4.1.1 Top Global Influenza Drugs and Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Influenza Drugs and Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Influenza Drugs and Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Influenza Drugs and Vaccines Price by Manufacturer (2017-2022)
4.2 Global Influenza Drugs and Vaccines Concentration Ratio (CR)
4.2.1 Influenza Drugs and Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Influenza Drugs and Vaccines in 2021
4.2.3 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Influenza Drugs and Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Influenza Drugs and Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Influenza Drugs and Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Influenza Drugs and Vaccines Market Size by Company
4.5.1 Top Influenza Drugs and Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Influenza Drugs and Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Influenza Drugs and Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Influenza Drugs and Vaccines Market Size by Region
5.1 Global Influenza Drugs and Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Influenza Drugs and Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Influenza Drugs and Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Influenza Drugs and Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Influenza Drugs and Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Influenza Drugs and Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Influenza Drugs and Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Influenza Drugs and Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Influenza Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Influenza Drugs and Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Influenza Drugs and Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Influenza Drugs and Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Influenza Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Influenza Drugs and Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Influenza Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Influenza Drugs and Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Corporation Information
7.1.2 Bristol Myers Squibb Description and Business Overview
7.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bristol Myers Squibb Influenza Drugs and Vaccines Products Offered
7.1.5 Bristol Myers Squibb Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Corporation Information
7.2.2 AstraZeneca Description and Business Overview
7.2.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 AstraZeneca Influenza Drugs and Vaccines Products Offered
7.2.5 AstraZeneca Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Corporation Information
7.3.2 Eli Lilly Description and Business Overview
7.3.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Eli Lilly Influenza Drugs and Vaccines Products Offered
7.3.5 Eli Lilly Recent Development
7.4 Roche
7.4.1 Roche Corporation Information
7.4.2 Roche Description and Business Overview
7.4.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Roche Influenza Drugs and Vaccines Products Offered
7.4.5 Roche Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporation Information
7.5.2 GlaxoSmithKline Description and Business Overview
7.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
7.5.5 GlaxoSmithKline Recent Development
7.6 Novartis
7.6.1 Novartis Corporation Information
7.6.2 Novartis Description and Business Overview
7.6.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Novartis Influenza Drugs and Vaccines Products Offered
7.6.5 Novartis Recent Development
7.7 Pfizer
7.7.1 Pfizer Corporation Information
7.7.2 Pfizer Description and Business Overview
7.7.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Pfizer Influenza Drugs and Vaccines Products Offered
7.7.5 Pfizer Recent Development
7.8 Sanofi Pasteur
7.8.1 Sanofi Pasteur Corporation Information
7.8.2 Sanofi Pasteur Description and Business Overview
7.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Sanofi Pasteur Influenza Drugs and Vaccines Products Offered
7.8.5 Sanofi Pasteur Recent Development
7.9 Bayer
7.9.1 Bayer Corporation Information
7.9.2 Bayer Description and Business Overview
7.9.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bayer Influenza Drugs and Vaccines Products Offered
7.9.5 Bayer Recent Development
7.10 Celgene
7.10.1 Celgene Corporation Information
7.10.2 Celgene Description and Business Overview
7.10.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Celgene Influenza Drugs and Vaccines Products Offered
7.10.5 Celgene Recent Development
7.11 Seqirus
7.11.1 Seqirus Corporation Information
7.11.2 Seqirus Description and Business Overview
7.11.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Seqirus Influenza Drugs and Vaccines Products Offered
7.11.5 Seqirus Recent Development
7.12 Protein Sciences Corporation
7.12.1 Protein Sciences Corporation Corporation Information
7.12.2 Protein Sciences Corporation Description and Business Overview
7.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Protein Sciences Corporation Products Offered
7.12.5 Protein Sciences Corporation Recent Development
7.13 Serum Institute of India
7.13.1 Serum Institute of India Corporation Information
7.13.2 Serum Institute of India Description and Business Overview
7.13.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Serum Institute of India Products Offered
7.13.5 Serum Institute of India Recent Development
7.14 Emergent Biosolutions
7.14.1 Emergent Biosolutions Corporation Information
7.14.2 Emergent Biosolutions Description and Business Overview
7.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Emergent Biosolutions Products Offered
7.14.5 Emergent Biosolutions Recent Development
7.15 BioCryst Pharmaceuticals
7.15.1 BioCryst Pharmaceuticals Corporation Information
7.15.2 BioCryst Pharmaceuticals Description and Business Overview
7.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.15.4 BioCryst Pharmaceuticals Products Offered
7.15.5 BioCryst Pharmaceuticals Recent Development
7.16 Alvogen
7.16.1 Alvogen Corporation Information
7.16.2 Alvogen Description and Business Overview
7.16.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Alvogen Products Offered
7.16.5 Alvogen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Influenza Drugs and Vaccines Industry Chain Analysis
8.2 Influenza Drugs and Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Influenza Drugs and Vaccines Distributors
8.3 Influenza Drugs and Vaccines Production Mode & Process
8.4 Influenza Drugs and Vaccines Sales and Marketing
8.4.1 Influenza Drugs and Vaccines Sales Channels
8.4.2 Influenza Drugs and Vaccines Distributors
8.5 Influenza Drugs and Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
